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Abstract 
Schistosomiasis, a disease affecting over 200,000,000 
human beings, Is caused by Infection with one of sev­
eral species of the Schistosoma trematodes. The In­
fectious form for mammals Is the cercaria developed 
by passage through snails. The major cause of death 
In those Infected results from distortion_ of the hepatic 
circulation caused by a unique kind of fibrosis In the 
liver. The fibrosis occurs In relation to the formation 
of nu�erous highly cellular and collagenous granu­
lomata as part of a cell-mediated immune response to 
eggs deposited by worms In the portal tract. After a 
period of tlme,·the granulomata disappear as new for­
mation of broad bands of collagen appear In the liver. 
Because of the nature of those bands the condition Is 
called pipestem fibrosis. The fibrosis distorts liver ar­
chitecture and with that the circulation of blood In the 
liver. Prevention of the disease by ecological controls 
directed largely against the snail vector, would seem 
to be most Important. Falling that, the disease Itself 
Is treated largely by use of a number of chemothera­
peutic agents directed against the Schistosoma. The 
present article reviews the modes of treatment now In 
use, and describes possible means of preventing or 
reversing the deposition of collagen that constitutes 
the fibrosis. Research on analogs of proline and lysine 
to Inhibit collagen biosynthesis or stimulate collagen 
degradation Is described. Possible new approaches 
for prevention of maturation and mating of worms 
lodged In ·portal tracts is considered as a means of 
preventing egg formation and the consequent host­
Immune response that causes fibrosis. 
Schistosomiasis, bilharziasis, is a worldwide problem of 
immense proportions affecting an estimated 200 million 
persons (Warren, 1980). It is a tropical disease concen­
trated among nations of northern and equatorial Africa, 
South America, Southeast Asia and Japan (Martinez-Baiz, 
1953). However, a significant number of cases are ap­
pearing in temperate climates of industrialized nations as 
a result 9f immigration and foreign travel from endemic 
areas (Warren et al., 1974). 
Three species of Schistosoma cause significant human 
disease: S. japonicum, S. mansoni and S. hematobium. 
Among the many signs and symptoms associated with 
schistosomiasis, hepatosplenic manifestations are largely 
responsible for the morbidity and mortality of the disease. 
Approximately 100 million people suffer from liver disease 
as a complication of S. mansoni and S. japonicum infec­
tions. It is no wonder that schistosomiasis ranks as a major 
cause of liver disease worldwide. 
The Parasite 
Schistosomes are trematodes that alternate generations 
between asexual multiplication in intermediate hosts and 
sexual reproduction in mammalian definitive hosts. The 
process may be seen to begin with contamination of water 
by human exc;retory waste containing schistosome eggs. 
The eggs hatch into miracidia, a form infectious for certain 
types of fresh water snails. In this intermediate host, mir­
acidia develop into cercariae, the infective form for mam­
mals. A single miracidium may produce up to 100,000 
cercariae. Cercariae emitted by the snails penetrate hu­
man skin and migrate to the lungs where they traverse 
the capillaries and enter the arterial circulation, eventually 
migrating to the liver. Sexual coupling of the worms occurs 
in the liver and portal vein. Paired schistosomes then mi­
grate to the mesenteric veins to lay eggs. A single pair 
can produce from 300 to 3, 000 eggs per day. However, 
more than 50 per cent of that number never leave the 
body of the host. A large proportion of these eggs appears 
in the portal blood washed by the flow to the liver and are 
trapped in the hepatic parenchyma. 
Pathogenesis and Pathophysiology 
The use of various animal models has contributed greatly 
to our understanding of how the parasite causes hepatic 
disease. It is now well established that the initial process 
in the development of fibrosis is the entrapment of schis­
tosome eggs in the hepatic microcirculation. Microcir­
culation studies in mice demonstrated that eggs alone do 
not cause any significant decrease of liver blood flow. 
However, a granulomatous response involving eosino­
phils, macrophages, lymphocytes, epithelioid cells and 
collagen fibers occurs around the eggs (Fig. 1 ). That re­
sults in formation of areas of avascular fibrosis which cause 
distortion of blood flow. Because the granulomatous re­
sponse was found to be transferable by injection of lymph 
node cells or spleen cells but not by serum, the response 
was proposed to be a cell-mediated reaction (Warren, 
1972). Granulomas maintained in vitro were found to elab­
orate various lymphokines, e.g. , macrophage migration 
inhibitory factor (Boros et al., 1973), eosinophil stimulation 
promotor (James and Colley, 1975), all of which may be 
involved in the cell immune regulation. In addition, gran-
The Einstein Quarterly Journal of Biology and Medicine 
Figure 1. A section of a liver from a mouse infected with Schistosoma 
mansoni. This specimen was taken eight weeks after administration 
ulomas were found to secrete a fibroblast stimulating fac­
tor (Wyler et al., 1978). 
The number of fibrotic lesions in the liver of an infected 
person progressively increases with the daily deposition 
of eggs. Collagen content is increased 10-20 fold over 
normal (Warren, 1966). Eventually adjacent granuloma­
tous foci coalesce and a "clay pipestem" fibrosis devel-
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of fifty cercariae. Note the eggs (with lateral spines) grouped in th8 
center of a large granuloma. 
ops. As a consequence of the deposition of the eggs i 
the portal radicals, the portal vasculature in particular is· 
constricted and portions obliterated. The result is a pr&: 
sinusoidal blockade with splenomegaly and dilated c 
laterals without significant hepatocellular damage. Thus, 
hepatic schistosomiasis is one of the few chronic liv 
diseases in which the initial insult is not associated wi 
parenchymal cell necrosis. Parenchymal function remai 
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essentially normal in the presence of marked portal-sys­
temic shunting (Warren et al. , 1965). Liver function is 
maintained, in part, because total liver blood flow remains 
within normal limits. This occurs by virtue of a compen­
satory increase in the arterial blood flow and growth of 
the arterial vascular tree (Bloch et al., 1972). Arterial neo­
vascularization has been investigated by microcirculation 
studies and found to be most prominent in areas of fibro­
sis. Clinically, those findings explain observations that, in 
schistosomiasis, bleeding due to portal-systemic collat­
erals is the most important cause of morbidity and mor­
tality, and that hepatic encephalopathy is unusual even 
after hematemesis (Warren et al., 1965). 
The Biochemical Basis of Flbrogenesls 
Hepatic fibrosis is a consequence of an excessive ac­
cumulation of collagen in the liver. Collagens are a het­
erogeneous group of polypeptides that have certain com­
mon properties: 1) An amino acid composition consisting 
of about 33% glycine, 24% imino acids (proline and hy­
droxyproline), and the presence of two characteristic hy­
droxylated amino acids (hydroxyproline and hydroxyly­
sine); 2) amino acid sequence in helical regions with glycine 
appearing as every third residue; and 3) each collagen 
molecule consists of a helix of three individual chains 
wound together to form a molecule of approximately 
300,000 daltons. 
At present, five relatively well described types of collagen 
are known (Types 1-V) (Bornstein and Sage, 1980). Each 
collagen contains genetically distinct ex chains and has 
characteristic tissue distribution and properties. In human 
liver, Types I, Ill, IV and V are present normally (Popper 
and Udenfriend, 1970; Chen and Leevy, 1975). By im­
munofluorescent techniques, Type I is mainly found in the 
broad bands of collagen in the portal triads; Types Ill and 
V are found in the reticulin fibers of the sinusoids (Biem­
pica et al. , 1980). Normal liver contains approximately 
equal amounts of Types I, Ill and V (Rojkind et al., 1979). 
Type IV is present in small amounts only. The proportions 
of the various constituent types of collagen have been 
observed to change with the development of fibrotic dis­
ease (Chen and Leevy 1975, Rojkind and Martinez-Pal­
oma, 1976; Rojkind et al., 1979). For example, in mild 
fibrosis the ratio of Type I to Type Ill collagens was found 
to be nearly normal, but with severe cirrhosis due to al­
cohol, hemochromatosis or Wilson's disease, Type I and 
the ratio of Type I to Type Ill were found to increase 
significantly (Seyer et al., 1977; Rojkind et al., 1979). In 
experimental schistosomiasis in mice, the ratio of collagen 
Type I to Type Ill was found to change from the normal 
of 1:1 to 2:1 in the late stages of the disease (Wu et al., 
1982). Apparently, a temporal pattern of collagen-type 
composition may be characteristic for a particular etiology 
of hepatic fibrosis. 
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Collagen Biosynthesis 
1) The Collagen Gene and Transcription 
In the past few years, recombinant DNA technology has 
been used to elucidate the structure of collagen genes. 
In particular the entire procollagen cx2 (pro-cx2) gene of 
Type I collagen (Sobel et al., 1978; Lehrach et al., 1979) 
and its promotor region (Vogeli et al., 1981) have been 
sequenced from chicken and sheep. Human Type I pro­
cx2 genes have been also partially purified (Myers et al., 
1981 ). 
The pro-cx2 gene is approximately 38-40 kilo base pairs 
(bp) in length; about eight times longer than the cyto­
plasmic pro-cx2 mRNA that is translated. Sequences of 
collagen genes have shown that, as in genes of many 
other proteins, structural regions (exons) exist separated 
by spacer regions (introns) (Boyd et al., 1980). The coding 
information in the pro-cx2 gene is subdivided into more 
than 50 exons that are interspersed with introns of various 
lengths. The pro-cx2 gene is unique in that seven out of 
eight of the exons that code for the helical region of the 
polypeptide have identical lengths (54 bp). The se­
quences within these exons vary except for the glycine 
codon that occurs at every third triplet. It has been sug­
gested that repeated 54 bp coding units imply that an 
ancestral collagen gene arose from multiple duplications 
or amplifications of a single genetic unit containing an 
exon of 54 bp (Yamada et al. , 1980). The sizes of the 
introns vary from 100 bp to 3000 bp. The sequences of 
the introns also vary considerably except at their 5' and 
3' ends (Avvedimento et al. , 1980). Sequences at the 5' 
end have been called "donors" and those at the 3' end 
"acceptors" (Lerner et al., 1980). Recently, there has been 
experimental evidence suggesting that a nuclear RNA, 
U1 RNA, is involved in the mRNA splicing reaction. The 
5' end of U1 RNA is complementary with both acceptor 
and donor ends of introns (Rogers, 1980). This brings the 
coding sequences that are to be spliced in juxtaposition. 
2) Translation 
In ways similar to those for other secretory proteins, pro­
alpha chains of collagen are synthesized on membrane 
bound ribosomes. A short hydrophobic sequence, the 
signal peptide at the amino terminus of the chain, allows 
the newly synthesized polypeptides to traverse the mi­
crosomal membrane into the cisternal space of the rough 
endoplasmic reticulum (Biobel and Dobberstein, 1975). 
The signal peptide is removed by cleavage before syn­
thesis of the chains is complete. 
There are at present several factors that are considered 
active in controlling translation of collagen: 1) Pools of 
prolyl and glycyl tRNAs; thus in experimental liver fibrosis 
induced by CCI4, increased levels of glycyl and prolyl 
tRNAs have been detected (Diaz de Leon, 1975). 2) In-
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tracellular proline pool; in vitro collagen synthesis in slices 
obtained from livers of mice infected with schistosomes 
and from livers of rats made fibrotic by administration of 
CCI4 showed a linear correlation between increased col­
lagen synthesis and extracellular proline concentration up 
to a limiting value (Ehrinpreis et al. , 1980; Dunn et al., 
1977). In livers of animals and humans with alcoholic liver 
cirrhosis, increased intracellular levels of free proline were 
obtained (Kershenobich et a!., 1970). In mice with schis­
tosomiasis, arginine was found to be the main precursor 
of proline in the liver (Dunn et a!., 1978b). Another con­
tributory factor to elevated levels of free proline may be 
decreased degradation as reflected by decreased levels 
of proline oxidase (Ehrinpreis et a!., 1980). 
3) Post-translational Modifications 
Procollagen o: chains undergo several rare kinds of post­
translational modifications. Certain proline and lysine res­
idues are hydroxylated. This is accomplished respectively 
by prolyl and lysyl hydroxylases. Lysyl hydroxylase re­
quires molecular oxygen and a-ketoglutarate as co-sub­
strates, and ascorbic acid and ferrous iron as co-factors 
(Kivirikko and Prockop, 1972). The substrate is a lysine 
residue linked to the amino group of a glycine residue in 
the molecule. There are at least two prolyl hydroxylases, 
both of which require ferrous iron, molecular oxygen, L­
ascorbic acid, and a-ketoglutarate (Cardinale and Uden­
friend, 1974). The proline residue in the third position (Y) 
of the Gly-X-Y sequences is preferentially hydroxylated. 
Underhydroxylated polypeptides, such as could occur in 
ascorbic acid deficiency, cannot form proper procollagen 
helices and are not secreted. Galactosyl and glucosyl 
transferases, using UDPgalactose and UDPglucose, 
transfer the respective sugar moieties. Galactose is linked 
directly to the hydroxyl group of certain hydroxylysine 
residues (Spiro and Spiro, 1971 ); the glucose residues, 
when present, are always attached to a galactose unit. 
After hydroxylation and addition of sugars, the procolla­
gen peptide chains spontaneously form a triple helix prior 
to secretion from the cells. 
4) Secretion 
The actual process of secretion requires packaging into 
Golgi-derived vesicles before exocytosis (Weinstock and 
Leblond, 1974). Golgi apparatus, secretory vesicles and 
microtubules are needed for transport. The procollagen 
that is secreted has propeptide extensions at both the 
amino and carboxyl termini. The molecular weight of the 
amino terminus is 15,000-20,000 daltons and that of the 
carboxyl end is 35,000-40,000 daltons. After secretion, 
specific peptidases cleave the propeptides from the main 
molecules (Duksin and Bornstein, 1977). The amino-ter­
minal propeptides have been shown to exert a feed-back 
inhibition of collagen synthesis in the human fibroblast 
system (Wiestner et a!., 1979) Similar inhibition of collagen 
synthesis by carboxyl-terminal propeptides has been 
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demonstrated recently (Personal communication, Koda, 
K., Betheil, J.J., and Seitter, S.). The propeptide exten­
sions appear to serve several functions: 1) Ensure proper 
secretion; 2) ensure proper alignment of the individual 
chains to form the triple helix; 3) prevent intracellular fi­
brogenesis; and 4) regulate synthesis by feedback con­
trbl. 
5) Collagen Fibril Formation 
After cleavage of the terminal propeptides, collagen mol­
ecules in the extracellular space aggregate as fibrils sta­
bilized by intra- and intermolecular crosslinks (Gallop et 
a!., 1972). Lysyl oxidase, a copper requiring enzyme (Sie­
gel and Fu, 1976), is responsible for oxidative deamination 
of the E-amino groups of selected lysyl and hydroxylysyl 
residues. Reactive aldehydes, thus formed, enable co­
valent crosslinks to occur by formation of Schiff bases 
and of aldol linkages between chains. Lathyrogenic agents 
such as (3-aminopropionitrile inhibit lysyl oxidase, prevent 
crosslinking and cause collagen of poor tensile strength 
to be deposited. The condition is known as lathyrism. A 
genetic equivalent of lathyrism is found in certain types 
of Ehler-Danlos syndromes. 
6) Collagen Degradation 
Native triple-helical collagens are cleaved at specific sites 
by tissue cdllagenases at physiological pH and temper­
ature. Cleavage occurs in each of the 3 o: chains near the 
carboxyl terminus and results in 75,000 and 225,000 dal­
ton fragments. Collagenases are usually present in in­
active forms and, under experimental conditions, require 
some kind of activation either dissociative or proteolytic. 
The mechanism of activation of latent tissue collagenase 
in vivo is not known at present. Liver collagenolytic activity 
has been studied in normal and fibrotic liver (Takahashi 
et a! . ,  1980). In the case of hepatic schistosomiasis, col­
lagenolytic activity is markedly increased in experimental 
animals several months after infection. However, that ac­
tivity decreases and becomes normal in late stages of the 
disease. 
Assessment of Hepatic Fibrosis 
The assessment of liver involvement in schistosomiasis is 
difficult since, at present, no fool-proof non-invasive method 
exists for determining the extent of hepatic fibrosis. Ide­
ally, a test for hepatic fibrosis should provide information 
about both the quantity of collagen present and the rate 
of collagen accumulation or diminution. In that way, the 
status and prognosis of the liver disease can be as­
sessed. 
Liver biopsy with histological staining for collagen has 
been used. extensively in the past. That kind of estimation 
is basically descriptive. Use of specific anti-procollagen 
sera in biopsy specimens has been shown to provide 
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accurate identification of various types of collagen pre­
sent as well as to give information about their location 
(Gay et al. , 1975). However, this approach is also semi­
quantitative, and suffers from the disadvantages inherent 
in microscopic examination of small biopsies: 1) Sampling 
error, 2) lack of assessment of fibrotic activity, 3) risk 
incurred by repeated biopsy for follow-up. 
More specific non-immune tests have been investigated 
and fall into two categories: 1) Measurement of collagen­
specific enzymes, and 2) measurement of collagen or 
collagen metabolites. 
The activity of prolyl hydroxylase was observed to in­
crease in several conditions associated with increased 
collagen deposition. It was proposed that assay of the 
enzymatic activity might reflect the rate of collagen syn­
thesis (Kivirikko and Ristelli, 1976). Prolyl hydroxylase 
measurements of liver specimens in animal models of 
hepatic injury as well as in patients with various liver dis­
eases were elevated (Takeuchi et al., 1969; Ristelli and 
Kivirikko, 1974). Measurement of serum prolyl hydroxy­
lase activity has been studied as a means of assessing 
fibrotic activity of the liver. The activity was significantly 
elevated in the majority of patients with active hepatic 
fibrosis and also in those with ongoing hepatic inflam­
mation. Values did not correlate with collagen content of 
biopsied specimens as measured by hydroxyproline. 
Nevertheless, this method was considered to indicate he­
patic collagen synthesis (Tuderman et al. , 1977; Kuutii­
Savolainen et al., 1979a). 
Another collagen-associated enzyme, galactosyl hydroxy­
lysyl glucosyl transferase, was assayed in serum of pa­
tients with various liver diseases. The results were similar 
to those obtained in studies of prolyl hydroxylase in terms 
of some correlation of elevated activity in fibrotic liver 
diseases and active parenchymal damage (Kuutii-Savo­
lainen et al., 1979b). 
Finally, lysyl oxidase, which initiates the extracellular 
crosslinking of collagen molecules, has been studied in 
experimental hepatic fibrosis. Its activity correlated with 
the formation of early connective tissue septa as deter­
mined histologically. The increase in lysyl oxidase activity 
was greater in magnitude than prolyl or lysyl hydroxylases 
(Siegel et al., 1978; Ristelli and Kivirikko, 1976). Similar 
findings in human liver tissue were noted (Fuller et al., 
1976). 
Recently, antibodies to the non-helical peptide extensions 
of the termini of procollagen have been obtained and a 
radioimmunoassay developed for their measurement. Al­
though the collagens used were from animals, significant 
cross-reactivity of the antisera with human procollagens 
permits detection of propeptides in human serum (Taub­
man et al., 1974; Rohde et al. , 1976). Radioimmunoassay 
has been performed using sera of persons with liver dys-
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function. The majority of patients with active liver disease 
of various etiologies had elevated amino-terminal pro­
peptide levels in serum. Inflammation and necrosis in 
biopsies from patients with alcoholic liver disease cor­
related best with elevation of propeptides (Rohde et al., 
1978). The presence of increased levels of collagen pro­
peptides is taken as evidence of increased synthesis and 
secretion of collagen as part of a fibrotic process. 
Therapy 
1) Schistosomicides 
The major objective of therapy has been the killing and 
elimination of adult worms to stop further deposition of 
eggs. A selection of drugs and their actions is shown in 
Table I. Results of several clinical trials have been re­
viewed recently (Katz, 1980; Pieron, 1980). The effective­
ness of a particular chemotherapeutic regimen depends 
on the drug, parasite characteristics and host factors. 
These topics cannot be discussed in detail in this article. 
However, several interesting aspects deserve comment. 
Although many drugs are called schistosomicides, some 
experts think that, in most instances, the parasite is not 
killed by the action of the drug alone. For example, in one 
study antimonials and oxamniquine, or their active me­
tabolites, never reached levels in the blood known to be 
sufficient to kill the parasite in vitro (Foster and Cheetham, 
1973). A mechanism by which therapeutic agents may 
cause destruction of worms without directly killing them 
was noted in early studies with antimonials. Following in­
jection of the drugs intravenously in man, a rapid dis­
placement of worms from the mesenteric veins to the por­
tal venules was observed. Most of the parasites were 
trapped within 30 min. (Goldsmith et al., 1967). Following 
the shift, a tissue reaction was noted surrounding worms 
in the liver in experimental mouse infections. That reaction 
consisted of leukocytic infiltration that then destroyed fe­
male schistosomes. A connective tissue reaction char­
acterized the response to the trapped male worms (Strei­
bel and Kradolfer, 1966). Thus, the drug effects that cause 
the hepatic shift as well as the host tissue reaction appear 
to' be factors in the therapeutic response of many schis­
tosomicidal agents. 
In general, to be effective, schistosomicidal drugs ap­
parently must be absorbed by the parasite. Considerable 
variability exists in terms of absorption of various agents 
among the different species of schistosomes, and even 
between different sexes of the same species. For ex­
ample, antimonials, niridazole (Hess et al., 1966), and 
hycanthone (Yanisky et al., 1970) showed greater uptake 
by female as compared to male worms. That was con­
sidered to have contributed to the relative ease with which 
females succumbed to drugs in early experiments. 
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Table I. Anti-Schistosoma/ Drugs 
Drug 
Potassium antimony tartrate 
Stibophen 
Antimony lithium thiomalate 
Sodium antimony gluconate 
Antimony dimercaptosuccinate 
Hycanthone 
Niridazole 
Oxamniquine 
Praziquanter• 
Amoscanate• 
•Experimental 
Actions on schistosomes 
inhibition of schistosome 
glycolysis (Mansour and 
Bueding, 1954) 
rapid inhibition of attachment 
to venous walls with passive 
shift to liver (Suttle 
and Khayyal, 1962) 
I 
interference with normal 
neuromuscular activity 
(Senft and Hillman, 
1973) 
increased glycogenolysis 
inhibition of monoamine 
oxidase (Kim et al., 1981) 
stimulation of glycogenolysis 
(Bueding and Mansour, 1957) 
damage to the female 
reproductive system 
motor paralysis (Woo/house. 
1979) 
inhibition of cholinesterases 
(Kim et al., 1981) 
tonic muscular contraction 
(Fetterer et al., 1980) 
not determined 
There is evidence that the stage of maturity of the worms 
is also an important factor in determining susceptibility to 
drugs. Experiments using antimonials demonstrated a lack 
of activity in animals infected with immature worms up to 
28 days after exposure. The activity became 100% at 
49-56 days. Furthermore, in unisexual infections, sexual 
maturity was not achieved, and none of the worms was 
noted to be susceptible even after an exposure of 173 
days. Since children are more frequently exposed to re­
infection than adults, and therefore more likely to harbor 
an immature worm population, a maturity-related sensi­
tivity might contribute to the relative resistance of infec­
tions in children. 
Differences in susceptibility of different Schistosoma spe­
cies to different agents have been noted but not well 
explained. In addition to interspecies variability, various 
strains within the same species also appear to differ in 
their susceptibility to the same drug (Nelson and Saoud, 
1968), perhaps accounting for some of the reported var­
iable clinical responses among patients infected with the 
same species of parasite. 
Age and weight of patients have also been reported to 
affect the outcome of therapeutic regimens. Children, as 
Susceptible species 
S. hematobium 
S. mansoni 
S. hematobium 
S. mansoni 
S. hematobium 
S. mansoni 
S. japonicum 
S. mansoni 
S. hematobium 
S. mansoni 
S. japonicum 
S. hematobium 
S. mansoni 
S. japonicum 
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Side effects 
nausea and vomiting; 
dyspnea; arthralgia, 
EKG changes 
nausea and vomiting; 
diarrhea; vertigo; 
headache; insomnia 
mutagenesis 
(experimentally) 
neuropsychic 
disturbances: 
confusion, psychosis, 
hallucinations, 
convulsions 
dizziness; nausea; 
headache; drowsiness 
dizziness; nausea; 
drowsiness; headache; 
diarrhea 
mentioned previously, have been found to be less re­
sponsive to treatment than adults (Newsome, 1956). The 
mechanism of that difference is undoubtedly complex and 
may involve differences in immune status, intensity of in­
fection, re-infection, as well as status of hepatic metabolic 
function. 
2) Anti-fibrotic Agents 
Although anti-schistosoma! drugs are designed to prevent 
further damage to the liver, they do not directly address 
the fibrosis and inflammatory processes already existing. 
On the other hand, anti-fibrotic agents are designed to 
reduce fibrosis and reverse the fibrotic process. Such 
agents are meant to take advantage of requirements and 
processes that are relatively specific for biosynthesis or 
degradation of collagen. Thus, potential anti-fibrotic agents 
may be directed against pro-a chain biosynthesis, hy­
droxylation and glycosylatio� reactions that are intracell­
ular post-translational modifications, secretion of procol­
lagen, processing of procollagen to collagen, and 
extracellular fiber formation and crosslinking. Another as­
pect of anti-fibrotic strategy is development of agents that 
may stimulate production or activation of collagenases. 
Experimentation with potential anti-fibrotic agents has been 
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fairly extensive using several models of hepatic fibrosis. 
Few have been applied to experimental schistosomiasis. 
In studies using the CCI4-induced hepatic fibrosis model 
in rats, administration of 3,4-dehydroproline was found to 
reduce the formation of collagen in the liver. In addition, 
the hepatic pool of free proline was observed to be re­
duced in relation to non-treated specimens. Non-colla­
genous protein synthesis was found to be normal (Rojkind, 
1973). Administration of azetidine 2-carboxylic acid to 
schistosome-infected mice caused a concentration-de­
pendent decrease in hepatic protein-bound hydroxypro­
line. In that case, also, a reduced concentration of free 
intracellular proline was measured (Dunn et al., 1977). 
Table II summarizes properties of selected anti-fibrotic 
agents. 
The Frontier 
Investigators in the Liver Research Center and the De­
partment of Biochemistry at the Albert Einstein College of 
Medicine have developed a very active research program 
concerning various aspects of hepatic schistosomiasis. 
Several projects currently in progress involve basic and 
Table II. Anti-fibrotic Agents 
Hydroxylase Inhibitor 
8,9 dihydroxy ?-methyl 
benzoquinodizinium 
bromide 
Proline Analogs 
Azetidine 2-carboxylic acid 
3,4-Dehydroproline 
cis fluoroproline } 
cis bromoproline · 
cis hydroxyproline 
Lysine Analogs 
4,5-Dehydrolysine 
Aminoethylcysteine 
Crosslink Inhibitors 
1'1-Aminopropionitrile 
Penicillamine 
Anti-Inflammatory Agents 
Colchicine 
Corticosteroids 
Mechanism of actions 
iron chelation 
competition with proline for 
transport and for prolyl 
!RNA 
inhibition of prolyl and lysyl 
hydroxylases; competition 
with proline for prolyl tRNA 
competition with proline for 
prolyl !RNA 
competition with lysine for 
lysyl !RNA 
competition with lysine for 
lysyl !RNA 
competitive inhibition of 
lysyl oxidase 
combines with free 
aldehydes in collagen; 
bound by lysyl oxidase; 
inhibits lysyl oxidase at 
high doses 
interferes with microtubule 
assembly; inhibits 
transcellular movement; 
may increase production 
and release of collagenase 
Inhibition of prolyl 
hydroxylase 
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applied biochemistry, pharmacology and clinical medi­
cine. 
1) Amino Acid Metabolic Alterations in Hepatic Fibrosis 
Because of the importance of proline as a structural com­
ponent of collagen and the evidence relating proline con­
centrations in cells to collagen synthetic rates, the pre­
cursors of proline and their relative contribution to regulation 
of the proline reservoir in fibrogenesis is important to de­
termine. Our laboratory, in collaboration with Dr. Sheila 
Cohen at Merck Laboratories, is examining the metabolic 
fluxes of amino acids in intact livers, normal and fibrotic, 
by using 13C NMR spectroscopy. While there are diffi­
culties involved in older techniques requiring isolation of 
free amino acids and their quantification, the NMR method 
possesses significant advantages in permitting the ex­
amination of intact liver by maintaining the organ in a 
continuous closed perfusion system while the sample is 
held in a specially designed probe. Precursors enriched 
with 13C at particular positions in the molecule are per­
fused and metabolic conversions of compounds are fol­
lowed by changes in chemical shifts of the specific label. 
Using a similar, more conventional approach, Dr. Sam 
Seitter is using specifically radiolabelled precursors to 
Effects 
reduced conversion of proline 
to hydroxyproline 
reduced hydroxylation of 
lysine and proline residues, 
reduced glycosylation of 
hydroxylysine residues 
reduced collagen extrusion 
decreased collagen extrusion 
decreased collagen synthesis 
and extrusion 
increased collagen solubility 
and susceptibility to 
collagenase 
increased collagen solubility 
and susceptibility to 
collagenase 
reduced collagen extrusion 
decreased collagen synthesis 
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study proline biosynthesis. Thus far, our most recent re­
sults confirm earlier in vitro studies in that arginine and 
ornithine can serve as substrates for the formation of pro­
line. Labelled glucogenic substrates were found to be 
converted to glutamic acid and glutamine but not to pro­
line suggesting that glutamic acid has little if any direct 
role in proline biosynthesis in fibrotic liver. The evidence 
indicates that the only detectable intrahepatic amino acid 
source of ornithine, the most immediate stable proline 
precursor, is arginine. Since arginine is an essential amino 
acid, the biosynthesis of proline in fibrotic liver appears 
to be exclusively dependent on delivery of arginine or 
ornithine from extrahepatic sources. Considering the tre­
mendous requirement for proline in fibrogenesis, the de­
pendence of the fibrotic liver on such a limited number 
of precursors is a remarkable phenomenon. 
2) Effects of New Lysine Analogs in Collagen Accumu­
lation in Hepatic Fibrosis 
Because of the importance of lysine in hydroxylation, gly­
cosylation and cross-linking functions in collagen, lysine 
analogs have several possible steps where they might 
interfere with the formation of a complete functional mol­
ecule. If lysine-like compounds could be made such that 
they are incorporated and act as natural lysine except 
that collagen-associated functions are inhibited, structural 
abnormalities could be made relatively specific for col­
lagen, and decreased synthesis or increased degradation 
might result. 
In our laboratory, we have chemically synthesized new 
lysine analogs that differ from natural lysine only in the 
substitution of a heteroatom in the a position. These an­
alogs were administered to granuloma cultures derived 
from livers of schistosome-infected mice. Preliminary re­
sults show a significant reduction in collagen biosynthesis 
as measured by the conversion of proline to hydroxypro­
line. The effects were found to be directly related to the 
concentration of analog present in the culture medium. 
Synthesis of proteins other than collagen was also re­
duced but to a lesser extent. Further experiments are in 
progress to determine whether or not changes occur in 
the structure of proteins and how that affects the relative 
contribution of early degradation to the overall accumu­
lation of newly formed collagen. 
3) Colchicine 
Colchicine has been studied in the treatment of hepatic 
fibrosis due to alcohol (Rojkind et al., 1973). Although 
the number of patients treated was small, colchicine ap­
peared to have had a beneficial effect in spite of continued 
alcohol intake. Those promising early studies generated 
much interest concerning the possible applicability of col­
chicine in treatment of hepatic fibrosis due to other etiol­
ogical agents. To answer that question, a large multi-
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center clinical study is under way; included in the patient 
population will be a significant number of cases of hepatic 
fibrosis due to schistosomiasis. Our laboratory, in collab­
oration with Dr. Michael Dunn at the Walter Reed Hospita!, 
will attempt to study the usefulness of procollagen peptide 
radioimmunoassay in assessing the severity and activity 
of the fibrosis and hope to correlate levels of procollagen 
peptides in serum as a function of response to therapy. 
Such antibodies have been developed by Drs. Koda, 
Betheil and Seitter at our institution. 
4) Schistosome Biology 
We are presently investigating several exciting aspects 
of schistosome biology that may provide new approaches 
to therapy. For example, little is presently known about 
how male and female schistosomes are able to locate 
each other in the myriad of venules in the liver. There is 
evidence that pheromone-like attractants are secreted by 
the worms and such materials stimulate worm migration 
toward the source (Imperia et al., 1980). In addition, it is 
known that female Schistosoma do not mature in vivo 
without the presence of males. The implication is that male 
parasites transfer a critical substance(s) to the females 
and, without fulfillment of this requirement, egg production 
cannot be accomplished. 
Our laboratory is interested in determining the nature of 
the attractant(s), maturation requirements and their mech­
anism of action with the intent of developing agents that 
interfere with the normal action in vivo. Prevention of suc­
cessful mating will preclude egg production and major 
sequelae of hepatic fibrosis. 
Conclusion 
Human schistosomiasis is an important cause of disease 
worldwide. Much of the morbidity and mortality is due to 
hepatic fibrosis as a result of a host cell-mediated immune 
reaction to the schistosome eggs trapped in the portal 
venules. 
Significant progress has been made in understanding the 
events that govern the process of fibrogenesis. However, 
our state of knowledge of the process still leaves a great 
deal to be desired. Major unknowns exist such as: The 
immune factors involved in the stimulation of collagen 
production, the cell types responsible for the major share 
of collagen production, the mechanism of collagen gene 
selection, exon splicing mechanisms, variables regulating 
the proportions of the different types of collagen during 
the stages of the disease, and the signals required to 
guide the molecules from golgi vesicles to the extracel­
lular space. 
Clearly, an improved understanding of the various as­
pects of schistosoma! infection and host reaction culmi-
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nating in the deposition of collagen is necessary to de­
velop and implement efficacious therapeutic measures. 
By exploiting processes that are relatively specific for col­
lagen synthesis or degradation, it may be possible to 
produce agents that specifically inhibit or reverse colla­
gen accumulation and thereby offer the hundreds of mil­
lions afflicted with the hepatic fibrosis an effective therapy 
in the future. 
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